Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fixed Dose Combination Tablets”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02014272
What this trial is testing

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers

Who this might be right for
Healthy Volunteers
Pfizer 28
Early research (Phase 1)Study completedNCT07201545
What this trial is testing

Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin

Who this might be right for
Healthy Subjects
Daiichi Sankyo 58
Early research (Phase 1)Ended earlyNCT01725672
What this trial is testing

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 20
Large-scale testing (Phase 3)Study completedNCT00541450
What this trial is testing

Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 492
Early research (Phase 1)Study completedNCT01068717
What this trial is testing

Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 27
Early research (Phase 1)Study completedNCT01947153
What this trial is testing

Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.

Who this might be right for
Healthy
Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT01879371
What this trial is testing

Relative Bioavailability of Ibuprofen From a Single Fixed Dose Combination Tablet of Ibuprofen and Caffeine Compared to Single Tablets of Ibuprofen and Ibuprofen Lysinate

Who this might be right for
Healthy
Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT04885660
What this trial is testing

Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects

Who this might be right for
Therapeutic Equivalency
The Affiliated Hospital of Qingdao University 92
Early research (Phase 1)Study completedNCT02475135
What this trial is testing

Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination

Who this might be right for
Healthy
Janssen Sciences Ireland UC 72
Post-approval studies (Phase 4)UnknownNCT03231982
What this trial is testing

Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan

Who this might be right for
Hypertension
HK inno.N Corporation 210
Early research (Phase 1)Study completedNCT01055691
What this trial is testing

A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets

Who this might be right for
Healthy Volunteers
AstraZeneca 120
Early research (Phase 1)WithdrawnNCT02395237
What this trial is testing

COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.

Who this might be right for
Healthy
Pharmaceutical Research Unit, Jordan
Early research (Phase 1)Study completedNCT00416728
What this trial is testing

Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.

Who this might be right for
Healthy
Novartis 32
Early research (Phase 1)Study completedNCT04317703
What this trial is testing

Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

Who this might be right for
Type 2 Diabetes
LG Chem 40
Early research (Phase 1)Study completedNCT02629354
What this trial is testing

To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet

Who this might be right for
Healthy
Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT01822639
What this trial is testing

A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study

Who this might be right for
Hypertension
GlaxoSmithKline 15
Early research (Phase 1)Study completedNCT01518712
What this trial is testing

Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64
Early research (Phase 1)Study completedNCT03467971
What this trial is testing

Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants

Who this might be right for
Healthy
Merck KGaA, Darmstadt, Germany 21
Not applicableStudy completedNCT05329857
What this trial is testing

The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.

Who this might be right for
To Determine Bioequivalence Under Fed Conditions
AET Laboratories Private Limited 60
Testing effectiveness (Phase 2)Study completedNCT02251717
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 114
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation